Eli Lilly & Co. vs Teleflex Incorporated
LLY vs TFX — side-by-side comparison from reported financials. LLY leads 9, TFX leads 3 of 12 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
| Metric | LLY | TFX |
|---|---|---|
| Price | $1 177.20 | $125.12 |
| Market cap | $1.05T | $5.30B |
| Revenue (TTM) | $79.7B | $6.05B |
| Revenue growth | +31.7% | -10.6% |
| Net margin | 33.5% | -16.7% |
| Free cash flow | $18.2B | $229M |
| Net cash (debt) | ($35.2B) | ($2.61B) |
| 1-year price return | +37.6% | +0.3% |
| P/E | 41.6 | 28.7 |
| P/E vs own history (cheap-side %) | 88% | 64% |
| Dividend yield | 0.52% | 1.13% |
| Return on equity | 93% | -32% |
| Altman Z-score | 7.10 | 1.93 |
| CV checks passed | 11 of 11 | 8 of 11 |
| Employees | 50,000 | 15,500 |
Full résumé-style profiles: LLY CV · TFX CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.